This week we review 5 stocks. Two that aren't quite ready, but we should watch carefully and three that I am buying this week. Going into the portfolio is a medical diagnostics stock that is an M&A target, a mental health stock that helps keep people on track and an international solar play that has had a rough time at home despite huge growth rates. I see triples in all their futures.